Titan Pharmaceuticals Inc. (TTNP)

0.3784 +0.0574 (+17.882%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.321

Price Open 0.409

Volume: 55.23M

Avg Volume: 7.68M

Market Cap: 11.39M

P/E Ratio -0.71

52 Wk Range 0.172-2.85



TTNP Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
29.12M
607,998
0.47
2.09%

2018-09-14
20.22M
1.06M
6.40
5.23%

2018-08-31
20.22M
625,607
12.45
3.09%

2018-08-15
20.22M
406,455
14.31
2.01%




TTNP Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-14
Q2 2018
N/A
-0.15 (2)
-0.04
0.11

2018-05-15
Q1 2018
AMC
-0.13 (1)
-0.12
0.01

2018-05-09
Q1 2018
N/A
0.00 (0)
-0.17
0.00

2018-04-02
Q4 2017
AMC
-0.17 (2)
-0.17
0.00

News

Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer (2018-10-02 07:00 PR Newswire)

SOUTH SAN FRANCISCO, Calif. , Oct. 2, 2018 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a commercial stage company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura long-term, continuous drug delivery technology,…

 


Statistics

Shares Outstanding: 30.1M

Top 15 Institution Percent: 20.30

Price To Sales: 2.55

Price To Book: 22.64

Revenue: 40000

Gross Profit: N/A

Cash: 11.69M

Debt: N/A

Return On Assets: -161.43

Return On Equity: -363.86

Profit Margin: N/A

Price History

Beta: 0.17

50-day Moving Avg: 0.51

200-day Moving Avg: 0.89

YTD Change: -72.97

5-day Change: 68.18

1-month Change: -33.61

3-month Change: -57.49

6-month Change: -60.99

1-year Change: -81.08

Revenue Per Share: 0.00

Revenue Per Employee: 3077.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Titan Pharmaceuticals Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.titanpharm.com

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development of pharmaceutical products.